logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
logo dark logoo light logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
mobile logo
  • 主頁
  • AM1480
  • AM1380
  • 華語電視 Sino TV
  • 聯繫我們
  • 抗疫送暖
July 22, 2021
Uncategorized

諾獎得主本庶佑:到2050年憑藉免疫療法可治療癌症

諾貝爾生理學或醫學獎得主、京都大學特別教授本庶佑6日下午在斯德哥爾摩的卡羅林斯卡學院舉行的頒奬典禮前的記者會上表示,預期癌症治療在未來數十年將取得長足進展,到2050年,幾乎所有癌症都能憑藉免疫療法得到治療。

與本庶一起獲得此次諾貝爾獎的美國德克薩斯大學教授詹姆斯・艾利森也出席了記者會。本庶介紹稱,將兩人各自參與開發的癌症治療藥等並用後,效果得到提升。他表示,免疫療法將成為今後治療的關鍵,艾利森引述包括黑色素瘤(Melanoma)在內部分腫瘤的治療大有進展說,免疫療法最終會被用來對抗大部分癌症,可與放射線治療或化療併用,就算無法完全根除腫瘤,人也能存活下來,但「世界不會沒有癌症」。本庶對兩人共同獲獎表示“高興”,並就在斯德哥爾摩重聚開玩笑地表示,“首次見面是去他家提議共同研究的時候,但他拒絕了”,引起了會場笑聲。

昨天上午,他與其他獲獎者一起參觀市內的諾貝爾博物館,並參加了在咖啡店座椅下方簽名的例行活動。今天下午,本庶佑還將發表題為《獲得性免疫的驚人幸運》的紀念演講。諾貝爾奬將在下週一(10日)頒奬,醫學、物理、化學和經濟學獎會在瑞典的斯德哥爾摩頒發,和平獎則在挪威奧斯陸。今年沒有文學獎。

分享:

SHARE THIS ARTICLE

by admin
0
0
Previous post 古巴人手機終可上網 薪資太低民眾負擔不起
Next post CNN紐約攝影棚傳有炸彈 深夜封街疏散

即時新聞

賓州警方執行搜捕令時遭槍擊 致三死兩傷

September 18, 2025

賓州警方執行搜捕令時遭槍擊 致三死兩傷

September 18, 2025

川普與英相施凱爾簽署科技協議 加強美英合作

September 18, 2025

擬重新設計堅尼路 紐約市交通局徵詢公眾意見

September 18, 2025

聯大會議和猶太新年將至 紐約市警公佈安全計劃

September 18, 2025
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Others

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

SAVE & ACCEPT

Terms and Conditions - Privacy Policy